SN Oncology Portfolio
We are pleased to share with you here an overview of the academic oncology journals within the Springer Nature portfolio.
You will find highlights of the research we have published on the Featured page, and current special issues and collections on the Collections page.
Oncology: Natural Killer Cell Therapy
Wednesday 30 November 2022, 10–11:30am Central Standard Time, 5–6:30pm Central European Time.
Please follow this link to view the recording of this webinar.
This webinar focusses on Natural Killer Cell Therapy. Our panellists discuss developments in this exciting research field and their global perspectives.
Panellists
- Chair: Torsten Tonn, TU Dresen, Germany
- Dan Kaufman, University of California, San Diego, USA
- Jianhua Yu, City of Hope National Medical Center, USA
- Subramaniam Malarkannan, Medical College of Wisconsin, USA
- Michael Burger, Goethe University Frankfurt, Germany
Programme
Introduction - Torsten Tonn
Engineering human pluripotent stem cells to produce immune cells with improved anti-tumor activity - Dan Kaufman
Natural killer cells and their engineering with CAR to share the road to cancer immunotherapy with CAR-T cells - Jianhua Yu
Single-cell transcriptomes reveal developmental and functional heterogeneity of human NK cells - Subramaniam Malarkannan
The CAR2BRAIN study: CAR-NK cell therapy for glioblastoma patients - Michael Burger
Panel Discussion - All panellists
Related collection: 'Natural Killer Cell Therapy' in Cancer Immunology, Immunotherapy.
Oncology: Circulating Markers
Tuesday 15 February 2022, 8–9:30am Eastern Standard Time, 2–3:30pm Central European Time, 9–10:30pm Hong Kong Time.
Please follow this link to view the recording of this webinar.
This webinar is the next part of a Springer Nature Oncology webinar series that brings together international experts to discuss ongoing developments in cancer research. The new webinar focusses on 'Circulating Markers for the detection of cancer', with speakers covering a range of tumour‐derived circulating markers including circulating nucleic acids, circulating tumour cells and tumour‐educated platelets. Our panellists discuss developments in this exciting research field and their global perspectives.
Panellists
- Chair: Klaus Pantel, University Medical Centre Hamburg-Eppendorf, Germany
- Dennis Lo, The Chinese University of Hong Kong, China
- Myron Best, Cancer Center Amsterdam, Netherlands
- Catherine Alix-Panabières, University Medical Center of Montpellier, France
Programme
Introduction - Klaus Pantel
ctDNA for cancer diagnostics - Dennis Lo
Tumor-educated platelets for cancer detection - Myron Best
Circulating tumor cells for cancer detection - Catherine Alix-Panabières
Panel Discussion - All panellists
Related collections: 'Liquid Biopsy' in British Journal of Cancer and 'Liquid Biopsy at the Frontier of Early Detection, Prognosis and Cancer Treatments' in Molecular Cancer.
Oncology: Emerging Therapeutic Approaches
Thursday 24 June 2021, 8-9.30 am (EDT), 2-3.30 pm (CET), 8-9.30 pm (CST)
Please follow this link to view the recording of this webinar.
This webinar is the first of a new series that brings together international experts to discuss ongoing developments in cancer research. This webinar focusses on emerging therapeutics, with speakers covering areas including immunotherapy, metabolic targets, and the treatment of lung and colorectal cancers. Our panellists discuss these developments, their ongoing challenges, and their global perspectives.
Panellists
- Alexia-Ileana Zaromytidou, Chief Editor of Nature Cancer
- Haidong Dong, Mayo Clinic, USA, Editor-in-Chief of Cancer Immunology, Immunotherapy
- Adrian Harris, University of Oxford, UK, Editor-in-Chief of British Journal of Cancer
- Jan Paul Medema, University of Amsterdam, Netherlands, Editor-in-Chief of Oncogenesis
- Yi-Long Wu, Guangdong Academy of Medical Sciences, Member of Springer Nature’s Oncology Regional Advisory Board, China
Programme
Introduction - Alexia-Ileana Zaromytidou
New Therapeutic Targets in Cancer Immunotherapy - Haidong Dong
Glycogen Metabolism is a New Target for Cancer Therapy - Adrian Harris
Vulnerabilities of Mesenchymal Colorectal Cancers - Jan Paul Medema
Emerging Therapeutic Approaches in Lung Cancer: Beyond PD-1/L1 and Precision Strategy - Yi-Long Wu
Panel Discussion - All panellists
